Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate Add-on vs Quetiapine Monotherapy in Mania
NCT00139074Phase 4Terminated
- Sponsor
- AstraZeneca
- Start
- Jul 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of valproic acid in bipolar disorder (BD) (2 arms), sponsored by AstraZeneca. Primary endpoint: Number of Responders at 2 weeks. Started Jul 2005; status: terminated.
02
Drugs
valproic acid
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00139074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139074.